Columvi
NDC 50242-127 · Genentech, Inc.
Generic nameGlofitamab
Dosage formCONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)GLOFITAMAB
Strength10 mg/10mL
Pharmacologic classBispecific CD20-directed CD3 T Cell Engager [EPC], CD20-directed Antibody Interactions [MoA], CD3 Receptor Agonists [MoA], CD3-directed Antibody Interactions [MoA], Cytochrome P450 Inhibitors [MoA], Increased Cytokine Activity [PE]
Marketing categoryBLA
Packages
50242-127-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-127-01) / 10 mL in 1 VIAL, SINGLE-DOSE
Billed under HCPCS
J9286 — Injection, glofitamab-gxbm, 2.5 mg Medicare Part B payment limit (ASP + 6%): $2864.68
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50242-125 — Glofitamab